NAMVONA Trademark

Trademark Overview

On Friday, July 24, 2015, a trademark application was filed for NAMVONA with the United States Patent and Trademark Office. The USPTO has given the NAMVONA trademark a serial number of 86704055. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2019. This trademark is owned by Glaxo Group Limited. The NAMVONA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
namvona

General Information

Serial Number86704055
Word MarkNAMVONA
Filing DateFriday, July 24, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 30, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 6, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 6, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 15, 2018EXTENSION 5 GRANTED
Wednesday, October 3, 2018EXTENSION 5 FILED
Thursday, October 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 3, 2018TEAS EXTENSION RECEIVED
Saturday, March 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 29, 2018EXTENSION 4 GRANTED
Thursday, March 29, 2018EXTENSION 4 FILED
Thursday, March 29, 2018TEAS EXTENSION RECEIVED
Friday, September 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2017EXTENSION 3 GRANTED
Wednesday, September 27, 2017EXTENSION 3 FILED
Wednesday, September 27, 2017TEAS EXTENSION RECEIVED
Friday, April 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2017EXTENSION 2 GRANTED
Tuesday, April 4, 2017EXTENSION 2 FILED
Tuesday, April 4, 2017TEAS EXTENSION RECEIVED
Wednesday, September 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2016EXTENSION 1 GRANTED
Monday, September 12, 2016EXTENSION 1 FILED
Monday, September 12, 2016TEAS EXTENSION RECEIVED
Tuesday, April 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 5, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, November 5, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 5, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, November 5, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 4, 2015ASSIGNED TO EXAMINER
Thursday, July 30, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 28, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

namvona pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological